Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung

Tsugumasa Kamata, Kuniko Sunami, Akihiko Yoshida, Kouya Shiraishi, Koh Furuta, Yoko Shimada, Hitoshi Katai, Shun Ichi Watanabe, Hisao Asamura, Takashi Kohno, Koji Tsuta

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80%); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.

Original languageEnglish
Pages (from-to)261-265
Number of pages5
JournalJournal of Thoracic Oncology
Volume11
Issue number2
DOIs
Publication statusPublished - 2016

Fingerprint

Lung
Mutation
Neoplasms
Freezing
Exons
Genes

Keywords

  • BRAF
  • Ciliated muconodular papillary tumors
  • EGFR
  • Histogenesis
  • Next-generation sequencing

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Kamata, T., Sunami, K., Yoshida, A., Shiraishi, K., Furuta, K., Shimada, Y., ... Tsuta, K. (2016). Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung. Journal of Thoracic Oncology, 11(2), 261-265. https://doi.org/10.1016/j.jtho.2015.10.021

Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung. / Kamata, Tsugumasa; Sunami, Kuniko; Yoshida, Akihiko; Shiraishi, Kouya; Furuta, Koh; Shimada, Yoko; Katai, Hitoshi; Watanabe, Shun Ichi; Asamura, Hisao; Kohno, Takashi; Tsuta, Koji.

In: Journal of Thoracic Oncology, Vol. 11, No. 2, 2016, p. 261-265.

Research output: Contribution to journalArticle

Kamata, T, Sunami, K, Yoshida, A, Shiraishi, K, Furuta, K, Shimada, Y, Katai, H, Watanabe, SI, Asamura, H, Kohno, T & Tsuta, K 2016, 'Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung', Journal of Thoracic Oncology, vol. 11, no. 2, pp. 261-265. https://doi.org/10.1016/j.jtho.2015.10.021
Kamata, Tsugumasa ; Sunami, Kuniko ; Yoshida, Akihiko ; Shiraishi, Kouya ; Furuta, Koh ; Shimada, Yoko ; Katai, Hitoshi ; Watanabe, Shun Ichi ; Asamura, Hisao ; Kohno, Takashi ; Tsuta, Koji. / Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung. In: Journal of Thoracic Oncology. 2016 ; Vol. 11, No. 2. pp. 261-265.
@article{5b45fe65b3df4b70aa571762ee2f0343,
title = "Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung",
abstract = "Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80{\%}); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.",
keywords = "BRAF, Ciliated muconodular papillary tumors, EGFR, Histogenesis, Next-generation sequencing",
author = "Tsugumasa Kamata and Kuniko Sunami and Akihiko Yoshida and Kouya Shiraishi and Koh Furuta and Yoko Shimada and Hitoshi Katai and Watanabe, {Shun Ichi} and Hisao Asamura and Takashi Kohno and Koji Tsuta",
year = "2016",
doi = "10.1016/j.jtho.2015.10.021",
language = "English",
volume = "11",
pages = "261--265",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "2",

}

TY - JOUR

T1 - Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung

AU - Kamata, Tsugumasa

AU - Sunami, Kuniko

AU - Yoshida, Akihiko

AU - Shiraishi, Kouya

AU - Furuta, Koh

AU - Shimada, Yoko

AU - Katai, Hitoshi

AU - Watanabe, Shun Ichi

AU - Asamura, Hisao

AU - Kohno, Takashi

AU - Tsuta, Koji

PY - 2016

Y1 - 2016

N2 - Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80%); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.

AB - Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80%); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.

KW - BRAF

KW - Ciliated muconodular papillary tumors

KW - EGFR

KW - Histogenesis

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=84958985631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958985631&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2015.10.021

DO - 10.1016/j.jtho.2015.10.021

M3 - Article

C2 - 26718882

AN - SCOPUS:84958985631

VL - 11

SP - 261

EP - 265

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 2

ER -